CLASS III Drug recall · Reported 18 Dec 2019 · FDA Enforcement Report

Clobetasol Propionate Foam, 0.05%, a) pack recalled

Glenmark Pharmaceuticals Inc., USA is recalling Clobetasol Propionate Foam, 0.05%, a) pack (, distributed nationwide in the US. The recall was initiated on 15 Nov 2019 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesa) 14190026, 14190028, 14190029, exp Feb-2021, 14190043, 14190045 exp Apr-2021 b) 14190024, 14190025, 14190027, exp Feb-2021, 14190030, 14190031, exp Mar-2021, 14190039, 14190042 exp Apr-2021, 14190047 exp May-2021, 14190062 exp Jul-2021
NDC68462-608
UPC0368462608944
Quantity recalleda) 34521 bottles; b) 16930 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0618-2020
FDA event ID
84282
Recalling firm
Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ
Manufacturer
Glenmark Pharmaceuticals Inc., USA
Classification
Class III
Status
Terminated
Recall initiated
15 Nov 2019
FDA classified
10 Dec 2019
Reported
18 Dec 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

15 Nov 2019Recall initiated by company
10 Dec 2019Classified by FDA+25 days
18 Dec 2019Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Defective delivery system; product is not foaming or is coming out as liquid.

Product as listed by the FDA

Clobetasol Propionate Foam, 0.05%, a) 50 g pack (NDC 68462-608-27) and b) 100 g pack (NDC 68462-608-94), Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd. Plot No.: B-25, MIDC, Shendra Aurangabad - 431210, Maharashtra, India Manufactured for: Glenmark Pharmaceuticas Inc. USA Mahwah, NJ 07430

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Defective delivery system; product is not foaming or is coming out as liquid.

Which lots are affected?

a) 14190026, 14190028, 14190029, exp Feb-2021, 14190043, 14190045 exp Apr-2021 b) 14190024, 14190025, 14190027, exp Feb-2021, 14190030, 14190031, exp Mar-2021, 14190039, 14190042 exp Apr-2021, 14190047 exp May-2021, 14190062 exp Jul-2021

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 84282
ReportedClassRecallCompanyReasonWhere
CLASS IIIClobetasol Propionate Foam (Emulsion Formulation), 0.05% a) pack recalledClobetasol PropionateGlenmark Pharmaceuticals Inc., USAOtherNationwide

More recalls from Glenmark Pharmaceuticals Inc., USA

All 141

Other Clobetasol Propionate recalls

All 21